Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Muscle Weakness × telitacicept × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 4 Muscle Weakness 1 Autoimmune Diseases 1

Interventions

telitacicept 1 fludarabine 1 Positron-Emission Tomography 1 Magnetic Resonance Imaging 1 Cyclophosphamide 1 Creatine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05737160 2025-05-23

Study of Telitacicept in Generalized Myasthenia Gravis

RemeGen Co., Ltd.

Phase 3 Completed

Autoimmune Diseases, Myasthenia Gravis, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡